The most frequently reported adverse experiences in association with the use of Sporanox were of gastrointestinal origin eg, dyspepsia, nausea, abdominal pain and constipation. Less frequently reported adverse experiences include headache, reversible increases in hepatic enzymes, menstrual disorder, dizziness and allergic reactions (eg, pruritus, rash, urticaria and angio-oedema). Isolated cases of peripheral neuropathy and of Stevens-Johnson syndrome have also been reported.
Especially in patients receiving prolonged (approximately 1 month) continuous treatment, cases of hypokalaemia, oedema, hepatitis and hair loss have been observed.